Author:
Rizio Avery A.,Bhor Menaka,Lin Xiaochen,McCausland Kristen L.,White Michelle K.,Paulose Jincy,Nandal Savita,Halloway Rashid I.,Bronté-Hall Lanetta
Abstract
Abstract
Purpose
Patients with sickle cell disease (SCD) may experience sickle cell-related pain crises, also referred to as vaso-occlusive crises (VOCs), which are a substantial cause of morbidity and mortality. The study explored how VOC frequency and severity impacts health-related quality of life (HRQoL) and work productivity.
Methods
Three hundred and three adults with SCD who completed an online survey were included in the analysis. Patients answered questions regarding their experience with SCD and VOCs, and completed the Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) and the Workplace Productivity and Activity Impairment: Specific Health Problem (WPAI:SHP). Differences in ASCQ-Me and WPAI:SHP domains were assessed according to VOC frequency and severity.
Results
Nearly half of the patient sample (47.2%) experienced ≥ 4 VOCs in the past 12 months. The most commonly reported barriers to receiving care for SCD included discrimination by or trouble trusting healthcare professionals (39.6%, 33.3%, respectively), limited access to treatment centers (38.9%), and difficulty affording services (29.4%). Patients with more frequent VOCs reported greater impacts on emotion, social functioning, stiffness, sleep and pain, and greater absenteeism, overall productivity loss, and activity impairment than patients with less frequent VOCs (P < 0.05). Significant impacts on HRQoL and work productivity were also observed when stratifying by VOC severity (P < 0.05 for all ASCQ-Me and WPAI domains, except for presenteeism).
Conclusions
Results from the survey indicated that patients with SCD who had more frequent or severe VOCs experienced deficits in multiple domains of HRQoL and work productivity. Future research should examine the longitudinal relationship between these outcomes.
Funder
Novartis Pharmaceuticals Corporation
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference34 articles.
1. Centers for Disease Control and Prevention. (2017). Sickle cell disease. Retrieved 11 April 2019, from https://www.cdc.gov/ncbddd/sicklecell/treatments.html.
2. National Heart, Lung, and Blood Institute. (2014). Evidence-based management of sickle cell disease: Expert panel report. https://www.nhlbi.nih.gov/health-topics/all-publications-and-resources/evidence-based-management-sickle-cell-disease-expert-0.
3. Bolaños-Meade, J., & Brodsky, R. A. (2009). Blood and marrow transplantation for sickle cell disease: Overcoming barriers to success. Current Opinion in Oncology. https://doi.org/10.1097/CCO.0b013e328324ba04.
4. Panepinto, J. A., & Bonner, M. (2012). Health-related quality of life in sickle cell disease: Past, present, and future. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.24176.
5. Wallen, G. R., Minniti, C. P., Krumlauf, M., Eckes, E., Allen, D., Oguhebe, A., et al. (2014). Sleep disturbance, depression and pain in adults with sickle cell disease. BMC Psychiatry. https://doi.org/10.1186/1471-244X-14-207.
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献